Funding
Turn ideas into impact
Show Me
Due: September 7, 2026
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
US $500,000
Type
Grant
Source
Federal
Opp Number
PA-25-163
Due: September 7, 2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-065
Due: September 7, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
PAR-25-095
Due: September 7, 2026
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-040
Due: September 8, 2026
National Centers for Biomedical Imaging and Bioengineering (NCBIB)
US $750,000
Type
Grant
Source
Federal
Due: September 25, 2026
NHLBI Program Project Applications (P01 Clinical Trials Optional)
Type
Grant
Source
Federal
Opp Number
PAR-24-065
Due: September 25, 2026
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-284
Due: September 25, 2026
Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-23-126
Due: September 25, 2026
Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-247
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?